{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:18:54Z","timestamp":1791227934784,"version":"4.1.0"},"reference-count":216,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.autrev.2025.103899","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T23:58:07Z","timestamp":1754438287000},"page":"103899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cognitive impairment in systemic autoimmune and inflammatory diseases: A narrative review focused on ANCA-associated vasculitis, sarcoidosis, Sj\u00f6gren's syndrome, systemic sclerosis, and Beh\u00e7et's disease"],"prefix":"10.1016","volume":"24","author":[{"given":"Marion","family":"Camard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Urbain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103899_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1474-4422(03)00262-X","article-title":"Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment","volume":"2","author":"DeCarli","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0010","doi-asserted-by":"crossref","first-page":"476","DOI":"10.7326\/0003-4819-109-6-476","article-title":"The reversible dementias: do they reverse?","volume":"109","author":"Clarfield","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2025.103899_bb0015","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1001\/jama.292.18.2237","article-title":"The metabolic syndrome, inflammation, and risk of cognitive decline","volume":"292","author":"Yaffe","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2025.103899_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3628","article-title":"Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy","volume":"11","author":"Millan","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2025.103899_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00002512-199915010-00002","article-title":"Drug-induced cognitive impairment in the elderly","volume":"15","author":"Moore","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.autrev.2025.103899_bb0030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41581-020-0266-9","article-title":"Mechanisms of cognitive dysfunction in CKD","volume":"16","author":"Viggiano","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.autrev.2025.103899_bb0035","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semarthrit.2018.02.007","article-title":"What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis","volume":"48","author":"Rayes","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103899_bb0040","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.57.3.496","article-title":"The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus","volume":"57","author":"Ainiala","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103899_bb0045","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1017\/S1355617701766106","article-title":"Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients","volume":"7","author":"Kozora","year":"2001","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.autrev.2025.103899_bb0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbi.2006.08.004","article-title":"Stress primes microglia to the presence of systemic inflammation: implications for environmental influences on the brain","volume":"21","author":"Perry","year":"2007","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2025.103899_bb0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.31887\/DCNS.2019.21.3\/pharvey","article-title":"Domains of cognition and their assessment","volume":"21","author":"Harvey","year":"2019","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.autrev.2025.103899_bb0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1017\/S1092852918001499","article-title":"Neuroinflammation and cognition across psychiatric conditions","volume":"24","author":"Fourrier","year":"2019","journal-title":"CNS Spectr"},{"key":"10.1016\/j.autrev.2025.103899_bb0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2022.11.003","article-title":"Inflammation-related functional and structural Dysconnectivity as a pathway to psychopathology","volume":"93","author":"Goldsmith","year":"2023","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.autrev.2025.103899_bb0070","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.autrev.2025.103899_bb0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/cells11030359","article-title":"Interconnections between Inflammageing and Immunosenescence during ageing","volume":"11","author":"Teissier","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2025.103899_bb0080","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3389\/fimmu.2017.01745","article-title":"Aging, obesity, and inflammatory age-related diseases","volume":"8","author":"Frasca","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103899_bb0085","doi-asserted-by":"crossref","first-page":"e1256","DOI":"10.1212\/WNL.0000000000007094","article-title":"Systemic inflammation during midlife and cognitive change over 20 years: the ARIC study","volume":"92","author":"Walker","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103899_bb0090","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fnins.2014.00375","article-title":"Obesity and cognitive decline: role of inflammation and vascular changes","volume":"8","author":"Nguyen","year":"2014","journal-title":"Front Neurosci"},{"key":"10.1016\/j.autrev.2025.103899_bb0095","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s40744-021-00312-0","article-title":"Cognitive dysfunction in systemic lupus erythematosus: immunopathology, clinical manifestations","volume":"8","author":"Seet","year":"2021","journal-title":"Neuroimag Manag Rheumatol Ther"},{"key":"10.1016\/j.autrev.2025.103899_bb0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12026-015-8716-3","article-title":"Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus","volume":"63","author":"Mackay","year":"2015","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2025.103899_bb0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbi.2015.09.001","article-title":"Dynamic microglial modulation of spatial learning and social behavior","volume":"55","author":"Torres","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2025.103899_bb0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","article-title":"Microglia biology: one century of evolving concepts","volume":"179","author":"Prinz","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2025.103899_bb0115","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bph.13139","article-title":"Microglial M1\/M2 polarization and metabolic states","volume":"173","author":"Orihuela","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.autrev.2025.103899_bb0120","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.autrev.2025.103899_bb0125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","article-title":"Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration","volume":"35","author":"Perry","year":"2013","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2025.103899_bb0130","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.neuroscience.2009.08.073","article-title":"Sustained expression of interleukin-1beta in mouse hippocampus impairs spatial memory","volume":"164","author":"Moore","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.autrev.2025.103899_bb0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbi.2013.04.002","article-title":"CNS-specific T cells shape brain function via the choroid plexus","volume":"34","author":"Baruch","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2025.103899_bb0140","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2015.08.055","article-title":"Inhibition of interleukin-6 abolishes the promoting effects of pair housing on post-stroke neurogenesis","volume":"307","author":"Meng","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.autrev.2025.103899_bb0145","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1523\/JNEUROSCI.22-02-00486.2002","article-title":"Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6","volume":"22","author":"Valli\u00e8res","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2025.103899_bb0155","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1172\/JCI133737","article-title":"Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease","volume":"130","author":"Roy","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2025.103899_bb0160","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1002\/art.25013","article-title":"Amelioration of brain pathology and behavioral dysfunction in mice with lupus following treatment with a tolerogenic peptide","volume":"60","author":"Lapter","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103899_bb0165","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3233\/JAD-200711","article-title":"Therapeutic potential of TNF-\u03b1 inhibition for Alzheimer\u2019s Disease prevention","volume":"78","author":"Torres-Acosta","year":"2020","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrn3484","article-title":"Emerging roles of astrocytes in neural circuit development","volume":"14","author":"Clarke","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.autrev.2025.103899_bb0175","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainresbull.2017.02.001","article-title":"Human astrocytes in the diseased brain","volume":"136","author":"Dossi","year":"2018","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.autrev.2025.103899_bb0180","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tins.2019.05.011","article-title":"Do astrocytes play a role in intellectual disabilities?","volume":"42","author":"Cresto","year":"2019","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.autrev.2025.103899_bb0185","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/QAI.0b013e3182237e54","article-title":"Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection","volume":"57","author":"Lyons","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.autrev.2025.103899_bb0190","doi-asserted-by":"crossref","first-page":"15369","DOI":"10.1523\/JNEUROSCI.2637-10.2010","article-title":"Deletion of CD14 attenuates Alzheimer\u2019s disease pathology by influencing the brain\u2019s inflammatory milieu","volume":"30","author":"Reed-Geaghan","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2025.103899_bb0195","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1212\/WNL.0000000000008682","article-title":"Association of CD14 with incident dementia and markers of brain aging and injury","volume":"94","author":"Pase","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103899_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196487","article-title":"Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with systemic lupus erythematosus and cognitive dysfunction","volume":"13","author":"Duarte-Garc\u00eda","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2025.103899_bb0205","first-page":"689","article-title":"Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis","volume":"29","author":"Greisen","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0210","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/infdis\/jiy337","article-title":"Normalization of soluble CD163 levels after institution of antiretroviral therapy during acute HIV infection tracks with fewer neurological abnormalities","volume":"218","author":"D\u2019Antoni","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0215","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1038\/s41598-019-42286-8","article-title":"Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice","volume":"9","author":"Zhao","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2025.103899_bb0220","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s13365-013-0181-y","article-title":"Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study","volume":"19","author":"Vassallo","year":"2013","journal-title":"J Neurovirol"},{"key":"10.1016\/j.autrev.2025.103899_bb0225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2025.103899_bb0230","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.autrev.2025.103899_bb0235","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41467-020-15224-w","article-title":"Lupus autoantibodies act as positive allosteric modulators at GluN2A-containing NMDA receptors and impair spatial memory","volume":"11","author":"Chan","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103899_bb0240","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/art.23399","article-title":"Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus","volume":"58","author":"Arinuma","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103899_bb0245","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1002\/art.38127","article-title":"Memory dysfunction in primary Sj\u00f6gren\u2019s syndrome is associated with anti-NR2 antibodies","volume":"65","author":"Lauvsnes","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103899_bb0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0255","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/bs.ircmb.2016.05.001","article-title":"Mutually supportive mechanisms of inflammation and vascular remodeling","volume":"326","author":"Whiteford","year":"2016","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.autrev.2025.103899_bb0260","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.3390\/ijms22147622","article-title":"Glucocorticoids: Fuelling the fire of atherosclerosis or therapeutic extinguishers?","volume":"22","author":"MacLeod","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103899_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.autrev.2025.103899_bb0270","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/jnnp-2019-321913","article-title":"Evidence-based prevention of Alzheimer\u2019s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials","volume":"91","author":"Yu","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2025.103899_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103899_bb0280","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/rheumatology\/kem107","article-title":"Prevalence of Wegener\u2019s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden","volume":"46","author":"Mohammad","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103899_bb0285","first-page":"1","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.autrev.2025.103899_bb0290","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.40313","article-title":"The epidemiology of Antineutrophil cytoplasmic autoantibody-associated Vasculitis in Olmsted County, Minnesota: a twenty-year US population-based study","volume":"69","author":"Berti","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0295","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/rheumatology\/kex293","article-title":"Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody\u2013associated vasculitis","volume":"56","author":"Pearce","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2025.103899_bb0300","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/BOR.0b013e32834115f9","article-title":"Neurological involvement in Wegener\u2019s granulomatosis","volume":"23","author":"Holle","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0305","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ana.410330103","article-title":"Neurological involvement in Wegener\u2019s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic","volume":"33","author":"Nishino","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0310","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.md.0000200166.90373.41","article-title":"Central nervous system involvement in Wegener granulomatosis","volume":"85","author":"Seror","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2025.103899_bb0315","series-title":"Microscopic Polyangiitis and Polyarteritis Nodosa: How and When Do They Start?","year":"2025"},{"key":"10.1016\/j.autrev.2025.103899_bb0320","first-page":"S65","article-title":"Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides","volume":"27","author":"Zhang","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0325","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(03)12518-4","article-title":"Churg-Strauss syndrome","volume":"361","author":"Noth","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2025.103899_bb0330","series-title":"Eosinophilic granulomatosis With Polyangiitis (Churg-Strauss): Clinical Characteristics and Long-term Followup of the 383 Patients Enrolled in the French Vasculitis Study Group Cohort","year":"2025"},{"key":"10.1016\/j.autrev.2025.103899_bb0335","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3389\/fneur.2018.01166","article-title":"Central nervous system involvement in ANCA-associated Vasculitis: what neurologists need to know","volume":"9","author":"Zheng","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0340","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-510X(02)00015-1","article-title":"Frequency and patterns of subclinical cognitive impairment in patients with ANCA-associated small vessel vasculitides","volume":"195","author":"Mattioli","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103899_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102424","article-title":"Complement alternative pathway in ANCA-associated vasculitis: two decades from bench to bedside","volume":"19","author":"Brilland","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103899_bb0350","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.3390\/ijms22126474","article-title":"Granulomatous inflammation in ANCA-associated Vasculitis","volume":"22","author":"M\u00fcller","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103899_bb0355","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fimmu.2013.00120","article-title":"The role of the innate immune system in granulomatous disorders","volume":"4","author":"Petersen","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103899_bb0360","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1017\/S1355617719000262","article-title":"No difference in cognitive dysfunction among patients with ANCA-associated Vasculitis, rheumatoid arthritis or chronic kidney Disease","volume":"25","author":"Alcocer-Castillejos","year":"2019","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.autrev.2025.103899_bb0365","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000443750","article-title":"Brain Microvasculature Involvement in ANCA Positive Vasculitis","volume":"41","author":"Gonz\u00e1lez-Su\u00e1rez","year":"2016","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0370","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/jlb.67.5.591","article-title":"The role of inflammation in vascular diseases","volume":"67","author":"Sullivan","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2025.103899_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00256","article-title":"Neutrophil extracellular traps in ANCA-associated Vasculitis","volume":"7","author":"S\u00f6derberg","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103899_bb0380","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2025.103899_bb0385","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ana.22055","article-title":"Atherosclerosis, dementia, and Alzheimer\u2019s Disease in the BLSA cohort","volume":"68","author":"Dolan","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0390","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/00325481.2019.1664256","article-title":"Cognitive deficits in vasculitis of the nervous system: a cross-sectional study","volume":"131","author":"Mullin","year":"2019","journal-title":"Postgrad Med"},{"key":"10.1016\/j.autrev.2025.103899_bb0395","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1590\/S1980-57642012DN06030010","article-title":"NEUROPSI battery subtest profile in subcortical vascular dementia and Alzheimer\u2019s disease","volume":"6","author":"Matioli","year":"2012","journal-title":"Dement Neuropsychol"},{"key":"10.1016\/j.autrev.2025.103899_bb0400","first-page":"48","article-title":"Cognitive impairment in patients with eosinophilic granulomatosis with polyangiitis (EGPA): service evaluation in a regional severe asthma Centre in north-West England","author":"Diver","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2025.103899_bb0405","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/rheumatology\/keu243","article-title":"Neural correlates of fatigue in granulomatosis with polyangiitis: a functional magnetic resonance imaging study","volume":"53","author":"Basu","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103899_bb0410","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023769","article-title":"Treatment of fatigue with physical activity and behavioural change support in vasculitis: study protocol for an open-label randomised controlled feasibility study","volume":"8","author":"Harper","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.autrev.2025.103899_bb0415","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/annrheumdis-2017-212713","article-title":"Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire","volume":"77","author":"Robson","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0420","first-page":"1","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.autrev.2025.103899_bb0425","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/157015911796557975","article-title":"Neurosarcoidosis","volume":"9","author":"Lacomis","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.autrev.2025.103899_bb0430","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/qjmed\/92.2.103","article-title":"Central nervous system sarcoidosis\u2014diagnosis and management","volume":"92","author":"Zajicek","year":"1999","journal-title":"QJM"},{"key":"10.1016\/j.autrev.2025.103899_bb0435","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000314225","article-title":"Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment","volume":"80","author":"Elfferich","year":"2010","journal-title":"Respiration"},{"key":"10.1016\/j.autrev.2025.103899_bb0440","first-page":"2","article-title":"Everyday cognitive failure in patients suffering from neurosarcoidosis","volume":"36","author":"Voortman","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0445","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/jdv.13246","article-title":"TNF-\u03b1: a treatment target or cause of sarcoidosis?","volume":"29","author":"Amber","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2025.103899_bb0450","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1212\/WNL.0000000000004644","article-title":"Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series","volume":"89","author":"Gelfand","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103899_bb0455","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbi.2016.09.011","article-title":"Systemic TNF-\u03b1 produces acute cognitive dysfunction and exaggerated sickness behavior when superimposed upon progressive neurodegeneration","volume":"59","author":"Hennessy","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2025.103899_bb0460","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/WNL.0b013e318225ae07","article-title":"Proinflammatory cytokines, sickness behavior, and Alzheimer disease","volume":"77","author":"Holmes","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103899_bb0465","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bbi.2014.05.005","article-title":"Modulatory effects of proinflammatory cytokines for action cascading processes \u2013 evidence from neurosarcoidosis","volume":"41","author":"Beste","year":"2014","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.autrev.2025.103899_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036316","article-title":"Soluble cytokine receptors (sIL-2R\u03b1, sIL-2R\u03b2) induce subunit-specific behavioral responses and accumulate in the cerebral cortex and basal forebrain","volume":"7","author":"Zalcman","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2025.103899_bb0475","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.euroneuro.2015.01.012","article-title":"Effects of fatigue on cognitive control in neurosarcoidosis","volume":"25","author":"Beste","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.autrev.2025.103899_bb0480","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0040-1710576","article-title":"The burden of Neurosarcoidosis: essential approaches to early diagnosis and treatment","volume":"41","author":"Voortman","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2025.103899_bb0485","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.rmed.2017.11.008","article-title":"Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: a prospective follow-up study","volume":"138S","author":"Hendriks","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2025.103899_bb0490","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.3390\/jcm11133594","article-title":"Cognitive difficulties and health-related quality of life in sarcoidosis: an analysis of the GRADS cohort","volume":"11","author":"Hoth","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2025.103899_bb0495","first-page":"369","article-title":"A prospective, one-year follow-up study of patients newly diagnosed with neurosarcoidosis","author":"Byg","year":"2022","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2025.103899_bb0500","first-page":"26","article-title":"Executive functions in sarcoidosis: a neurocognitive assessment study","volume":"35","author":"Top\u00e7uo\u011flu","year":"2018","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0505","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 ACR-EULAR classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0510","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sj\u00f6gren\u2019s syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2025.103899_bb0515","doi-asserted-by":"crossref","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","article-title":"The geoepidemiology of Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Mavragani","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103899_bb0520","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/rheumatology\/29.1.21","article-title":"The spectrum of neurological involvement in Sj\u00f6gren\u2019s syndrome","volume":"29","author":"Andonopoulos","year":"1990","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2025.103899_bb0525","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005792-198207000-00004","article-title":"Neurologic complications of primary Sj\u00f6gren\u2019s syndrome","volume":"61","author":"Alexander","year":"1982","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2025.103899_bb0530","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2025.103899_bb0535","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0404.1994.tb01629.x","article-title":"Neurological and neuropsychiatric dysfunction in primary Sj\u00f6gren\u2019s syndrome","volume":"89","author":"Mauch","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2025.103899_bb0540","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/brainsci9040085","article-title":"Cognitive function in primary Sj\u00f6gren\u2019s syndrome: a systematic review","volume":"9","author":"Manzo","year":"2019","journal-title":"Brain Sci"},{"key":"10.1016\/j.autrev.2025.103899_bb0545","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/acn3.51123","article-title":"Cognitive impairment in patients with neuro-Sj\u00f6gren","volume":"7","author":"Seeliger","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0550","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s004150170135","article-title":"Neurological complications of primary Sj\u00f6gren\u2019s syndrome","volume":"248","author":"Lafitte","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0555","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/ard.2008.090811","article-title":"Cognitive function and 99m Tc-ECD brain SPECT are significantly correlated in patients with primary Sj\u00f6gren syndrome: a case\u2013control study","volume":"69","author":"Le Guern","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0560","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7326\/0003-4819-103-3-344","article-title":"Neuropsychiatric dysfunction in primary Sj\u00f6gren\u2019s syndrome","volume":"103","author":"Malinow","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2025.103899_bb0565","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0404.2009.01293.x","article-title":"Is there progressive cognitive dysfunction in Sj\u00f6gren syndrome? A preliminary study: progressive cognitive dysfunction in SS","volume":"122","author":"Mart\u00ednez","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2025.103899_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/501327","article-title":"Cognitive dysfunction and dementia in primary Sj\u00f6gren\u2019s syndrome","volume":"2013","author":"Blanc","year":"2013","journal-title":"ISRN Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0575","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006384","article-title":"Impact of pain on cognitive functions in primary Sj\u00f6gren syndrome with small fiber neuropathy: 10 cases and a literature review","volume":"96","author":"Indart","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2025.103899_bb0580","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0404.2011.01530.x","article-title":"Primary Sjogren\u2019s syndrome: cognitive symptoms, mood, and cognitive performance","volume":"125","author":"Segal","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2025.103899_bb0585","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s00415-003-0153-x","article-title":"Magnetic resonance abnormalitiesassociated with cognitive dysfunction in primary Sj\u00f6grenSyndrome","volume":"250","author":"Matar\u00f3","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0590","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1600-0404.1993.tb04242.x","article-title":"Aseptic meningoencephalitis in primary Sj\u00f6gren\u2019s syndrome","volume":"88","author":"Gerraty","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2025.103899_bb0595","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archderm.1987.01660300123025","article-title":"Sj\u00f6gren\u2019s syndrome. Association of cutaneous vasculitis with central nervous system disease","volume":"123","author":"Alexander","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084605","article-title":"Neurological involvement in primary Sj\u00f6gren syndrome: a focus on central nervous system","volume":"9","author":"Morreale","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2025.103899_bb0605","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2008.098301","article-title":"Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sj\u00f6gren syndrome: a comparative population-based study","volume":"68","author":"Harboe","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0610","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2004.01.019","article-title":"Autoantibodies against cerebral muscarinic cholinoceptors in Sj\u00f6gren syndrome: functional and pathological implications","volume":"150","author":"Reina","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2025.103899_bb0615","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1002\/art.38852","article-title":"Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sj\u00f6gren\u2019s syndrome","volume":"66","author":"Lauvsnes","year":"2014","journal-title":"Arthrit Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0620","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2016.12.002","article-title":"Clinical utility of circulating anti-N-methyl-d-aspartate receptor subunits NR2A\/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome: an updated meta-analysis","volume":"16","author":"Tay","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103899_bb0625","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1756-185X.12912","article-title":"Primary Sj\u00f6gren\u2019s syndrome is associated with significant cognitive dysfunction","volume":"19","author":"Tezcan","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0630","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00415-020-10290-y","article-title":"Neurofilament light is a biomarker of brain involvement in lupus and primary Sj\u00f6gren\u2019s syndrome","volume":"268","author":"Tjensvoll","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0635","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/03009742.2013.809143","article-title":"Cerebrospinal Flt3 ligand correlates to tau protein levels in primary Sj\u00f6gren\u2019s syndrome","volume":"42","author":"Dehlin","year":"2013","journal-title":"Scand J Rheumatol"},{"issue":"Suppl. 112","key":"10.1016\/j.autrev.2025.103899_bb0640","first-page":"190","article-title":"Association between primary Sj\u00f6gren\u2019s syndrome, cardiovascular and cerebrovascular disease: a systematic review and meta-analysis","volume":"36","author":"Yong","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0645","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1468-1331.2009.02537.x","article-title":"Cerebral white matter hyperintensities are not increased in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"16","author":"Harboe","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0650","first-page":"598","article-title":"Central nervous system involvement in Sj\u00f6gren\u2019s syndrome: evidence from neuropsychological testing and HMPAO-SPECT","volume":"150","author":"Belin","year":"1999","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.autrev.2025.103899_bb0655","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s10072-015-2204-3","article-title":"Intracranial hemodynamic changes in primary Sj\u00f6gren syndrome: a transcranial Doppler case-control study","volume":"36","author":"Morreale","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103899_bb0660","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08990220.2019.1604333","article-title":"P300 values in patients diagnosed with primary Sjogren syndrome","volume":"36","author":"Yava\u015fo\u011flu","year":"2019","journal-title":"Somatosens Mot Res"},{"key":"10.1016\/j.autrev.2025.103899_bb0665","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/0961203320908936","article-title":"Altered hippocampal functional connectivity in primary Sj\u00f6gren syndrome: a resting-state fMRI study","volume":"29","author":"Zhang","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103899_bb0670","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00234-022-02970-5","article-title":"Altered white matter structural connectivity in primary Sj\u00f6gren\u2019s syndrome: a link-based analysis","volume":"64","author":"Zhang","year":"2022","journal-title":"Neuroradiology"},{"key":"10.1016\/j.autrev.2025.103899_bb0675","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/rheumatology\/keq070","article-title":"Disruption of brain white matter microstructure in primary Sj\u00f6gren\u2019s syndrome: evidence from diffusion tensor imaging","volume":"49","author":"Segal","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103899_bb0680","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/ard.61.9.774","article-title":"Abnormal regional cerebral blood flow on 99mTc ECD brain SPECT in patients with primary Sj\u00f6gren\u2019s syndrome and normal findings on brain magnetic resonance imaging","volume":"61","author":"Chang","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0685","first-page":"773","article-title":"Technetium-99m-HMPAO brain SPECT in Sj\u00f6gren\u2019s syndrome","volume":"39","author":"Kao","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.autrev.2025.103899_bb0690","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00296-002-0272-1","article-title":"Detecting abnormal regional cerebral blood flow in patients with primary Sj\u00f6gren\u2019s syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain\u2014a preliminary report","volume":"23","author":"Huang","year":"2003","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2025.103899_bb0695","doi-asserted-by":"crossref","first-page":"199","DOI":"10.17712\/nsj.2019.3.20180027","article-title":"Montreal cognitive assessment in primary sjogren\u2019s syndrome","volume":"24","author":"Kurtulu\u015f","year":"2019","journal-title":"Neurosciences (Riyadh)"},{"key":"10.1016\/j.autrev.2025.103899_bb0700","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/1756-185X.13889","article-title":"Cognitive dysfunction in Sj\u00f6gren\u2019s syndrome using the Montreal cognitive assessment questionnaire and the automated neuropsychological assessment metrics: a cross-sectional study","volume":"23","author":"Riega-Torres","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0705","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/annrheumdis-2020-eular.4780","article-title":"Ab0411 cognitive impairment in primary Sj\u00f6gren\u2019s syndrome: a case-control study","volume":"79","author":"Mart\u00ednez","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0710","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.586","article-title":"Cognition, depression, fatigue, and quality of life in primary Sj\u00f6gren\u2019s syndrome: correlations","volume":"6","author":"Ko\u00e7er","year":"2016","journal-title":"Brain Behav"},{"key":"10.1016\/j.autrev.2025.103899_bb0715","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.3899\/jrheum.140362","article-title":"Validation of the brief cognitive symptoms index in Sj\u00f6gren syndrome","volume":"41","author":"Segal","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0720","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10067-013-2453-6","article-title":"Characterization of cognitive dysfunction in Sj\u00f6gren\u2019s syndrome patients","volume":"33","author":"Epstein","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0725","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jns.2012.07.060","article-title":"Prevalence of Sj\u00f6gren\u2019s syndrome with dementia in a memory clinic","volume":"322","author":"Yoshikawa","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103899_bb0730","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.semarthrit.2018.06.007","article-title":"Risk of dementia among patients with Sjogren\u2019s syndrome: a nationwide population-based cohort study in Taiwan","volume":"48","author":"Chen","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103899_bb0735","doi-asserted-by":"crossref","first-page":"1027044","DOI":"10.3389\/fnint.2022.1027044","article-title":"Risk of dementia or Parkinson\u2019s disease in the presence of Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis","volume":"16","author":"Wang","year":"2022","journal-title":"Front Integr Neurosci"},{"key":"10.1016\/j.autrev.2025.103899_bb0740","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3390\/jcm11071979","article-title":"Hospitalization risks for neurological disorders in primary Sj\u00f6gren\u2019s syndrome patients","volume":"11","author":"Goulabchand","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2025.103899_bb0745","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clim.2019.04.009","article-title":"Sjogren\u2019s syndrome: an update on disease pathogenesis, clinical manifestations and treatment","volume":"203","author":"Vivino","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103899_bb0750","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.1038\/s41598-022-17354-1","article-title":"The interplay between cognition, depression, anxiety, and sleep in primary Sjogren\u2019s syndrome patients","volume":"12","author":"Goulabchand","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2025.103899_bb0755","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neurom.2022.08.461","article-title":"The effects of noninvasive Vagus nerve stimulation on fatigue in participants with primary Sj\u00f6gren\u2019s syndrome","volume":"26","author":"Tarn","year":"2023","journal-title":"Neuromodulation"},{"key":"10.1016\/j.autrev.2025.103899_bb0760","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/rheumatology\/keab190","article-title":"Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis","volume":"60","author":"Bairkdar","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2025.103899_bb0765","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0770","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103899_bb0775","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.semarthrit.2013.05.002","article-title":"Neurologic involvement in scleroderma: a systematic review","volume":"43","author":"Amaral","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103899_bb0780","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/annrheumdis-2020-eular.6142","article-title":"Sat0339 nervous system involvement in systemic sclerosis: a cohort study","volume":"79","author":"Porel","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0785","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/annrheumdis-2016-eular.5190","article-title":"FRI0256 significance of cognitive impairment in systemic sclerosis","volume":"75","author":"Groseanu","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0790","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s10067-019-04884-9","article-title":"Evaluation of cognitive function in systemic sclerosis patients: a pilot study","volume":"39","author":"Khedr","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0795","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1051\/medsci\/20163202012","article-title":"Physiopathologie de la scl\u00e9rodermie syst\u00e9mique","volume":"32","author":"Allanore","year":"2016","journal-title":"Med Sci (Paris)"},{"key":"10.1016\/j.autrev.2025.103899_bb0800","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor\u2013\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2025.103899_bb0805","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.reumae.2019.07.005","article-title":"Evaluation of brain changes in systemic sclerosis (SSc) patients using two different techniques of MRI: is it really worthy?","volume":"17","author":"Gamal","year":"2021","journal-title":"Reumatol Cl\u00edn (English Edition)"},{"key":"10.1016\/j.autrev.2025.103899_bb0810","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/rheumatology\/39.12.1366","article-title":"Evidence of cerebral hypoperfusion in scleroderma patients","volume":"39","author":"Cutolo","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103899_bb0815","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1749-6632.2002.tb04241.x","article-title":"Brain functional involvement by perfusion SPECT in systemic sclerosis and Beh\u00e7et\u2019s disease","volume":"966","author":"Nobili","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2025.103899_bb0820","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1468-1331.2009.02714.x","article-title":"Cognitive and cerebral hemodynamic impairment in scleroderma patients","volume":"16","author":"Giuliodori","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0825","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.54.10.853","article-title":"Increased prevalence of symptomatic macrovascular disease in systemic sclerosis","volume":"54","author":"Veale","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0830","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/annrheumdis-2015-eular.1903","article-title":"FRI0488 prevalence and clinical significance of cognitive impairment in systemic sclerosis","volume":"74","author":"Amaral","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0835","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/archneur.1992.00530360094024","article-title":"Neurologic manifestations of progressive systemic sclerosis","volume":"49","author":"Averbuch-Heller","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0840","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.STR.22.3.410","article-title":"Scleroderma and central nervous system vasculitis","volume":"22","author":"Pathak","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.autrev.2025.103899_bb0845","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12888-023-04995-3","article-title":"Low cognitive functioning and depressive symptoms in patients with rheumatoid arthritis and systemic sclerosis: a clinical study","volume":"23","author":"Alexopoulos","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.autrev.2025.103899_bb0850","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/WNN.0b013e3182593c75","article-title":"Dysexecutive syndrome: a specific pattern of cognitive impairment in systemic sclerosis","volume":"25","author":"Yilmaz","year":"2012","journal-title":"Cogn Behav Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0855","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s10067-019-04468-7","article-title":"Neurosonological and cognitive screening for evaluation of systemic sclerosis patients","volume":"38","author":"Sakr","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0860","first-page":"keac004","article-title":"Cognitive difficulties in people with systemic sclerosis: a qualitative study","author":"Chen","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2025.103899_bb0865","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et\u2019s disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2025.103899_bb0870","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/1744666X.2016.1205486","article-title":"Behcet\u2019s disease: epidemiology, clinical manifestations, and diagnosis","volume":"13","author":"Davatchi","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103899_bb0875","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","article-title":"HLA-B51\/B5 and the risk of Beh\u00e7et\u2019s disease: a systematic review and meta-analysis of case-control genetic association studies","volume":"61","author":"de Menthon","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103899_bb0880","first-page":"1078","article-title":"Criteria for diagnosis of Behcet\u2019s disease","volume":"335","author":"Disease","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2025.103899_bb0885","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","author":"Disease (ITR-ICBD) IT for the R of the IC for B","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2025.103899_bb0890","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2004.02.021","article-title":"Cognitive impairment in Beh\u00e7et\u2019s disease patients without overt neurological involvement","volume":"220","author":"Monastero","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103899_bb0895","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.3390\/jcm12093149","article-title":"Psychiatric symptoms and cognitive disorders in Beh\u00e7et\u2019s Disease: a single-center, cross-sectional study","volume":"12","author":"Urbain","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2025.103899_bb0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2013.01.024","article-title":"Cognitive impairment in Brazilian patients with Beh\u00e7et\u2019s disease occurs independently of neurologic manifestation","volume":"327","author":"Dutra","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103899_bb0905","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s00415-004-0391-6","article-title":"P300 and neuropsychological evaluation in Beh\u00e7et\u2019s disease with and without neurological manifestations","volume":"251","author":"G\u00f6k\u00e7ay","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0910","doi-asserted-by":"crossref","DOI":"10.5152\/npa.2017.19406","article-title":"Cognitive functioning and silent neurological manifestations in Beh\u00e7et\u2019s Disease with ocular involvement","author":"Altunkaynak","year":"2017","journal-title":"Arch Neuropsychiatr"},{"key":"10.1016\/j.autrev.2025.103899_bb0915","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s10067-011-1725-2","article-title":"Silent central nervous system involvement in Egyptian Beh\u00e7et\u2019s disease patients: clinical, psychiatric, and neuroimaging evaluation","volume":"30","author":"Zayed","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0920","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1749-6632.2009.04670.x","article-title":"Cognitive functioning in Beh\u00e7et\u2019s disease","volume":"1173","author":"Cavaco","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2025.103899_bb0925","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s004150050317","article-title":"Neuropsychological follow-up of 12 patients with neuro-Beh\u00e7et disease","volume":"246","author":"Oktem-Tan\u00f6r","year":"1999","journal-title":"J Neurol"},{"issue":"Pt 11","key":"10.1016\/j.autrev.2025.103899_bb0930","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Beh\u00e7et\u2019s disease: evaluation of 200 patients. The Neuro-Beh\u00e7et Study Group","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2025.103899_bb0935","first-page":"77","article-title":"Clinicopathological study on a case of neuro-Beh\u00e7et\u2019s disease: in special reference to MRI, SPECT and neuropathological findings","volume":"48","author":"Arai","year":"1994","journal-title":"Jpn J Psychiatry Neurol"},{"key":"10.1016\/j.autrev.2025.103899_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152509","article-title":"Brain white matter microstructural alterations in Behcet\u2019s syndrome correlate with cognitive impairment and disease severity: a diffusion tensor imaging study","volume":"68","author":"Kargin","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103899_bb0945","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-3083.2012.02694.x","article-title":"Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Beh\u00e7et\u2019s disease: BAFF is correlated with progressive dementia and psychosis","volume":"75","author":"Sumita","year":"2012","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2025.103899_bb0950","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/clin.1996.4268","article-title":"Cerebrospinal fluid interleukin-6 in progressive Neuro-Beh\u00e7et\u2019s syndrome","volume":"82","author":"Hirohata","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2025.103899_bb0955","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11011-014-9551-2","article-title":"Interleukin 6 and cognitive dysfunction","volume":"29","author":"Trapero","year":"2014","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb0960","first-page":"1575","article-title":"IL-6 blockade for Beh\u00e7et\u2019s disease: review on 31 anti-TNF naive and 45 anti-TNF experienced patients","volume":"40","author":"Arida","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.autrev.2025.103899_bb0965","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-3083.2006.01844.x","article-title":"Levels of IL-15 in serum and cerebrospinal fluid of patients with Beh\u00e7et\u2019s disease","volume":"64","author":"Hamzaoui","year":"2006","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2025.103899_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116831","article-title":"Laboratory and clinical correlates of brain atrophy in neuro-Beh\u00e7et\u2019s disease","volume":"414","author":"G\u00fcnd\u00fcz","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2025.103899_bb0975","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1440-1819.2006.01533.x","article-title":"Executive dysfunctions and depression in Beh\u00e7et\u2019s disease without explicit neurological involvement","volume":"60","author":"Erberk-Ozen","year":"2006","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.autrev.2025.103899_bb0985","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2014.15","article-title":"Diagnosis and management of neuropsychiatric SLE","volume":"10","author":"Hanly","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0990","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.40591","article-title":"Review: nervous system Disease in systemic lupus erythematosus: current status and future directions","volume":"71","author":"Hanly","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb0995","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/acr.23243","article-title":"Cognitive impairment in rheumatoid arthritis: a systematic review","volume":"70","author":"Meade","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2025.103899_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105298","article-title":"Cognitive impairment in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"89","author":"Pankowski","year":"2022","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2025.103899_bb1005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/rheumatology\/keab452","article-title":"Cognitive dysfunction and associated neuroimaging biomarkers in antiphospholipid syndrome: a systematic review","volume":"61","author":"Donnellan","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103899_bb1010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-181294","article-title":"Relationship of antiphospholipid antibodies to risk of dementia: a systematic review","volume":"69","author":"Bucci","year":"2019","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb1020","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/acr.21691","article-title":"Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus","volume":"64","author":"Murray","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2025.103899_bb1025","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/art.23098","article-title":"General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus","volume":"57","author":"Tomietto","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103899_bb1030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","author":"Liang","year":"1999","journal-title":"Arthrit Rheumatol"},{"key":"10.1016\/j.autrev.2025.103899_bb1035","first-page":"61","article-title":"Distinctive cognitive profiles in Alzheimer\u2019s disease and subcortical vascular dementia","volume":"75","author":"Graham","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2025.103899_bb1040","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.autrev.2025.103899_bb1050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1533317515592331","article-title":"From subjective cognitive complaints to dementia","volume":"31","author":"Mendon\u00e7a","year":"2016","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.autrev.2025.103899_bb1055","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.wnl.0000180938.69146.5e","article-title":"Results of intervention for lupus patients with self-perceived cognitive difficulties","volume":"65","author":"Harrison","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103899_bb1060","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/brainsci11030346","article-title":"Neuroimaging correlates of cognitive dysfunction in adults with multiple sclerosis","volume":"11","author":"Petracca","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.autrev.2025.103899_bb1065","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.neurobiolaging.2011.09.009","article-title":"The potential of functional MRI as a biomarker in early Alzheimer\u2019s disease","volume":"32","author":"Sperling","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.autrev.2025.103899_bb1070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/rheumatology\/keab256","article-title":"The effects of disease activity on neuronal and behavioural cognitive processes in systemic lupus erythematosus","volume":"61","author":"Barraclough","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103899_bb1075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1037\/a0016035","article-title":"The Association of Anxiety and Depressive Symptoms with cognitive performance in community-dwelling older adults","volume":"24","author":"Beaudreau","year":"2009","journal-title":"Psychol Aging"},{"key":"10.1016\/j.autrev.2025.103899_bb1080","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.semarthrit.2021.09.008","article-title":"Longitudinal relationships between cognitive domains and depression and anxiety symptoms in systemic lupus erythematosus","volume":"51","author":"Bingham","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103899_bb1085","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1065","article-title":"Cognitive implications of rheumatoid arthritis: a call for comprehensive care and research focus","volume":"11","author":"Qidwai","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.autrev.2025.103899_bb1090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1742395319836472","article-title":"A systematic review of the association between fatigue and cognition in chronic noncommunicable diseases","volume":"17","author":"Menzies","year":"2021","journal-title":"Chronic Illn"},{"key":"10.1016\/j.autrev.2025.103899_bb1095","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1176\/ajp.147.10.1297","article-title":"Cognitive effects of corticosteroids","volume":"147","author":"Wolkowitz","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.autrev.2025.103899_bb1100","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/13548506.2020.1736312","article-title":"Effects of cognitive behavioral therapy for patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"25","author":"Shen","year":"2020","journal-title":"Psychol Health Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:53:56Z","timestamp":1763769236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225001600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":216,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1568997225001600"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103899","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive impairment in systemic autoimmune and inflammatory diseases: A narrative review focused on ANCA-associated vasculitis, sarcoidosis, Sj\u00f6gren's syndrome, systemic sclerosis, and Beh\u00e7et's disease","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103899"}}